BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3021678)

  • 21. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contributions of nuclear endocrinology to the diagnosis of adrenal tumors.
    Shapiro B; Fig LM; Gross MD; Khafagi F
    Recent Results Cancer Res; 1990; 118():113-38. PubMed ID: 2236834
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of I-131-meta-iodobenzylguanidine in the treatment of malignant pheochromocytoma. Description of 2 cases].
    Jakubowski W; Feltynowski T; Woy-Wojciechowski J; Leowska E; Liziniewicz A
    Pol Tyg Lek; 1986 Oct; 41(43):1386-8. PubMed ID: 3822916
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nuclear medicine diagnosis of pheochromocytoma].
    Farahati J; Reiners C
    Zentralbl Chir; 1997; 122(6):443-6. PubMed ID: 9334110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical applications of radio-labelled mIBG].
    Lumbroso J; Schlumberger M
    Rev Prat; 1990 Jan; 40(2):140-2. PubMed ID: 2300771
    [No Abstract]   [Full Text] [Related]  

  • 26. [Scintigraphic imaging of benign and malignant tumors of the sympathetic nervous system with meta-iodobenzylguanidine].
    Kimmig B; Brandeis WE; Eisenhut M; Bubeck B; Georgi P
    Rontgenblatter; 1985 May; 38(5):154-8. PubMed ID: 4012198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis, monitoring and therapy of neuroblastoma using I-131 meta-iodobenzylguanidine].
    Melino G; Taucci M; De Nardo D; Clerico A; Mango L; Antolini M; Caputo V; Castello MA
    Minerva Pediatr; 1986 Dec; 38(23-24):1083-93. PubMed ID: 3561358
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
    Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
    Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Horizons in radionuclide therapy: 1985 update.
    Beierwaltes WH
    J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):3-8. PubMed ID: 9002740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [131I-metaiodobenzylguanidine: diagnostic and therapeutic value].
    Simó R; Mesa J
    Med Clin (Barc); 1986 Nov; 87(14):597-601. PubMed ID: 3784681
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of malignant pheochromocytoma treated by 131I-metaiodobenzylguanidine.
    Theilade K; Bak M; Olsen K; Nielsen SL; Christensen NJ
    Acta Oncol; 1988; 27(3):296-7. PubMed ID: 3415861
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy of carcinoid tumors with [131I] meta-iodo-benzyl-guanidine.
    Adolph J; Kimmig B; Eisenhut M; Georgi P
    Recent Results Cancer Res; 1988; 110():281-5. PubMed ID: 3406506
    [No Abstract]   [Full Text] [Related]  

  • 36. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 131I-metaiodobenzylguanidine--a new agent for scintigraphic imaging and treatment of pheochromocytoma.
    Fischer M; Vetter W; Winterberg B; Vetter H
    Nuklearmedizin; 1984 Apr; 23(2):77-9. PubMed ID: 6473116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal iodine-131-meta-iodobenzylguanidine activity.
    Geatti O; Shapiro B; Shulkin B; Hutchinson R; Sisson JC
    Am J Physiol Imaging; 1988; 3(4):188-91. PubMed ID: 3214594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
    Nakabeppu Y; Nakajo M
    Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.